Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| American Health Packaging | 60687-637 | SUBLINGUAL | 2 mg in 1 1 | 5/9/2023 | |
| SpecGx LLC | 0406-8005 | SUBLINGUAL | 0.5 mg in 1 1 | 1/3/2024 | |
| Rhodes Pharmaceuticals L.P. | 42858-601 | SUBLINGUAL | 0.5 mg in 1 1 | 12/28/2023 | |
| Mylan Pharmaceuticals Inc. | 0378-8767 | SUBLINGUAL, BUCCAL | 2 mg in 1 1 | 3/31/2021 | |
| Mylan Pharmaceuticals Inc. | 0378-8765 | SUBLINGUAL, BUCCAL | 0.5 mg in 1 1 | 3/31/2021 | |
| Alvogen Inc. | 47781-355 | SUBLINGUAL, BUCCAL | 0.5 mg in 1 1 | 3/30/2018 | |
| Sun Pharmaceutical Industries, Inc. | 62756-969 | SUBLINGUAL | 0.5 mg in 1 1 | 11/6/2023 | |
| Accord Healthcare, Inc | 16729-549 | SUBLINGUAL | 0.5 mg in 1 1 | 5/3/2023 | |
| Bryant Ranch Prepack | 72162-1347 | SUBLINGUAL | 2 mg in 1 1 | 3/12/2024 | |
| Bryant Ranch Prepack | 71335-1296 | SUBLINGUAL | 0.5 mg in 1 1 | 7/20/2022 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
Authorised | 11/10/2017 | ||
Authorised | 11/9/2017 |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.